ArticleCancer letters2025

Comparison of Food and Drug Administration expedited approvals and guideline updates: A case study of immune checkpoint inhibitors in colon cancer care.

Danea M Horn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.